title: Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in Taiwan.
abstract: Facioscapulohumeral muscular dystrophy (FSHD) has been found to be linked to chromosome 4qter. A chromosome 4q35-ter marker, pFR-1 (subclone of the cosmid c51), has been recently isolated and used as a probe for mapping near, or within, the FSHD gene. To examine FSHD-associated DNA rearrangements in the Taiwan population, we used the pFR-1 probe to perform Southern blot analysis on 142 individuals, including 32 FSHD patients within 9 autosomal dominant families, five sporadic FSHD patients from 4 families (include one pair of twins), three sporadic scapuloperoneal syndrome (SPS) patients and two sporadic polymyositis patients with their unaffected parents, and 29 healthy controls. In 29 healthy individuals, 3 SPS and 2 polymyositis patients with their families, probe pFR-1 analysis revealed that all had polymorphic restriction fragments that were larger than 28 kb in length. All but 1 FSHD-affected individual had specific smaller EcoRI fragments (ranging in size from 10.5 to 27 kb). Two point linkage analysis between pFR-1 and the FSHD locus provided significant evidence for FSHD linkage (Z(max)=6.84). A similar smaller fragment was also present in 5 sporadic patients, while this smaller fragment could not be found in one of their parents. Identical EcoRI restriction fragment length polymorphism (RFLP) patterns linked to FSHD were shown in the monozygotic twins, even though they showed extreme variability in the expression of FSHD. We conclude that the pFR-1 probe is a tightly linked marker of FSHD and can be used to detect most DNA rearrangements associated with this disease in the Taiwan population. However, the same RFLP patterns may represent extreme variability in the expression of the FSHD gene.
authors.affiliation: Department of Neurology, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan, R.O.C.
authors.forename: Y D
authors.initials: YD
authors.lastname: Hsu
authors.forename: M C
authors.initials: MC
authors.lastname: Kao
authors.forename: W C
authors.initials: WC
authors.lastname: Shyu
authors.forename: J C
authors.initials: JC
authors.lastname: Lin
authors.forename: N E
authors.initials: NE
authors.lastname: Huang
authors.forename: H F
authors.initials: HF
authors.lastname: Sun
authors.forename: K D
authors.initials: KD
authors.lastname: Yang
authors.forename: W L
authors.initials: WL
authors.lastname: Tsao
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015139:Blotting, Southern; D002648:Child; D002874:Chromosome Mapping; D002894:Chromosomes, Human, Pair 4; D003001:Cloning, Molecular; D003360:Cosmids; D004247:DNA / Q000097:blood; D005190:Family; D005260:Female; D005819:Genetic Markers; D006801:Humans; D008285:Major Histocompatibility Complex; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000145:classification / Q000235:genetics* / Q000503:physiopathology; D010375:Pedigree; D012016:Reference Values; D013624:Taiwan
chemical_list: D005819:Genetic Markers; D004247:DNA